RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 118 filers reported holding RELMADA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.57 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $377,064 | +54.8% | 125,688 | +27.0% | 0.00% | – |
| Q2 2023 | $243,510 | +6728.7% | 98,988 | +6173.0% | 0.00% | – |
| Q1 2023 | $3,566 | -82.7% | 1,578 | -73.3% | 0.00% | – |
| Q4 2022 | $20,637 | -90.8% | 5,913 | -2.8% | 0.00% | – |
| Q3 2022 | $225,000 | +800.0% | 6,084 | +358.1% | 0.00% | – |
| Q2 2022 | $25,000 | -30.6% | 1,328 | 0.0% | 0.00% | – |
| Q1 2022 | $36,000 | -50.0% | 1,328 | -58.5% | 0.00% | – |
| Q4 2021 | $72,000 | -41.9% | 3,197 | -32.3% | 0.00% | – |
| Q3 2021 | $124,000 | -16.2% | 4,719 | +2.1% | 0.00% | – |
| Q2 2021 | $148,000 | -35.7% | 4,621 | -29.4% | 0.00% | – |
| Q1 2021 | $230,000 | -3.4% | 6,546 | -11.8% | 0.00% | – |
| Q4 2020 | $238,000 | +12.8% | 7,419 | +32.2% | 0.00% | – |
| Q3 2020 | $211,000 | -43.6% | 5,614 | -32.9% | 0.00% | – |
| Q2 2020 | $374,000 | +259.6% | 8,361 | +174.8% | 0.00% | – |
| Q1 2020 | $104,000 | -37.3% | 3,043 | -28.5% | 0.00% | – |
| Q4 2019 | $166,000 | – | 4,257 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Guild Investment Management, Inc. | 205,300 | $615,900 | 1.03% |
| Deep Track Capital, LP | 2,837,818 | $8,513,454 | 0.33% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 974,082 | $2,922,246 | 0.23% |
| apricus wealth, LLC | 77,362 | $239,822 | 0.21% |
| Palo Alto Investors LP | 732,400 | $2,197,200 | 0.21% |
| RTW INVESTMENTS, LP | 2,131,835 | $6,395,505 | 0.14% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $300,000 | 0.09% |
| AdvisorShares Investments LLC | 112,908 | $338,724 | 0.09% |
| Savior LLC | 3,500 | $10,500 | 0.07% |
| Spotlight Asset Group, Inc. | 20,000 | $60,000 | 0.05% |